The aim of this meta-analysis was to assess the effectiveness and safety of the combination
of clopidogrel and aspirin in patients with mild ischemic stroke or transient ischemic attack …

The optimal duration of dual antiplatelet therapy (DAPT) as a routine treatment in stroke
patients is still controversial. The efficacy and safety of DAPT may vary with different …

Background and purpose Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for
90 days was recommended as the secondary prevention of minor ischaemic strokes or …

Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …

Objective To present the systematic assessment on the efficacy and bleeding adverse
events of dual-antiplatelet therapy with aspirin and clopidogrel versus aspirin-mono …

Background and Purpose—Antiplatelets are recommended for patients with acute
noncardioembolic stroke or transient ischemic attack. We compared the safety and efficacy …

Background: Evidence about the use of dual antiplatelet therapy (DAPT) with aspirin and
P2Y12 inhibitors in patients with acute minor ischemic stroke or transient ischemic attack …

Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …

To improve the efficacy over antiplatelet monotherapy, dual antiplatelet therapy (DAPT) has
been increasingly adopted in the management of non-cardioembolic stroke. For minor …

Background: This study compared the effectiveness of dual antiplatelet therapy (DAPT) with
clopidogrel-aspirin with that of aspirin monotherapy (AM) in mild-to-moderate acute ischemic …